| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.23 |
2e-06 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-06 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
| mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.17 |
9e-05 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
CAY10576 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |